PE Anti-Human CD123 Antibody [6H6] (AGEL1456)

PE Anti-Human CD123 Antibody [6H6]

The Human CD123 Monoclonal Antibody (PE-conjugated, 6H6, AGEL1456) offered by AssayGenie is a cutting-edge tool for researchers studying CD123, a cell surface marker associated with various hematological malignancies. With a specific binding capacity to human CD123, this monoclonal antibody is designed for flow cytometry applications, enabling precise identification and characterization of CD123-expressing cells in research settings.CD123, also known as interleukin-3 receptor alpha chain, is a critical biomarker widely studied in the context of hematopoietic disorders such as acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Its overexpression has been linked to disease progression and poor prognosis in certain malignancies, making it a target of interest for therapeutic interventions and prognostic assessments.

By utilizing the Human CD123 Monoclonal Antibody (PE-conjugated, 6H6, AGEL1456), researchers can accurately profile and quantify CD123-positive cell populations in biological samples, facilitating the advancement of studies in cancer biology, immunotherapy, and targeted treatment strategies. This antibody provides a reliable tool for unraveling the complexities of CD123 biology and its implications in hematological malignancies, paving the way for innovative research discoveries and potential clinical applications.

Isotype:	Mouse IgG1, κ
Isotype Control:	PE Mouse IgG1, κ Isotype Control[MOPC-21]
Form:	Liquid
Conjugation:	PE
Recommended Use:	Each lot of this antibody is quality control tested by flow cytometric analysis. The amount of the reagent is suggested to be used 5 µL of antibody per test (million cells in 100 µL staining volume or per 100 µL of whole blood). Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use.
Spectrum: